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ABSTRACT 
Heterocyclic compounds possess diverse  biological properties that has lead to intense study and research of these compounds. One of these compounds is 
oxadiazole which has been found to exhibit various pharmacological activities. Oxadiazole is a five membered heterocyclic ring which is a versatile lead 
compound for designing potent bioactive agents. It exists in four isomeric forms. Out of its four isomers 1, 3, 4-oxadizole exhibited a wide range of biological 
activities  which  includes  antibacterial,  antitubercular,  anticonvulsant,  hypoglycemic,  antiallergic,  enzyme  inhibitor,  vasodialatory,  antifungal,  cytotoxic, 
antiinflammatory, analgesic, hypolipidemic, anticancer, insecticidal, ulcerogenic activities etc. The 1,3,4-Oxadiazole have shown significant antimicrobial 
activity against a wide variety of microorganisms like fungi, Gram +ve strains such as Staphylococcus aureus, Bacillus subtilis and Bacillus lintus and Gram –
ve strains such as Escherichia coli, Vibrio cholera and Pseudomonas aeruginosa. Oxadiazole derivatives and investigation of their chemical and biological 
behavior have  gained more importance in recent  decades  for biological,  medical and agricultural reasons. A large number  of drugs used  clinically have 
oxadiazole ring as a structural building block. The capacity of 1, 3, 4-oxadiazole nucleus to undergo variety of chemical reactions including electrophillic 
substitution,  nucleophilic  substitution, thermal and photochemical  which  make it  medicinal  backbone  on  which a number of potential  molecules  can  be 
constructed. Present review is flooded with reports of antimicrobial activity of 1,3,4-oxadiazole derivatives published in various journals. 
Keywords: 1,3,4-oxadiazoles, Antimicrobial Activity,  
 
INTRODUCTION 
The  chemistry  of  heterocyclic  compounds  has  been  an 
interesting  field  of  study  for  a  long  time.Oxadiazole  is  a 
cyclic  compound  containing  one  oxygen  and  two  nitrogen 
atoms in a five member ring.
1 Oxadiazoles have occupied a 
unique place in the field of medicinal chemistry due to its 
wide  range  of  activities.
2  From  the  literature  survey  1,3,4-
Oxadiazole nucleus has been found to possess antimicrobial
3, 
antifungal
4,  antiinflammatory
5,  anticonvulsant
6,  antioxidant, 
analgesic
7  and    mutagenic  activity.
8  One  pot  synthesis  of 
1,3,4-oxadiazoles  by  the  reaction  of  appropriate  hydrazide 
and  carboxylic  acid  has  been  reported.
9  Combining 
biphenyltetrazole  with  substituted  1,3,4-oxadiazole  by  -
SCH2-  moiety  is  expected  to  give  novel  heterocyclic 
compounds with better biological activities.
10 Derivatives of 
oxadiazole  are  used  in  the  market  such  as  (Tiodazosin, 
Nosapidil,  Furamizole).
11  Some  material  applications  of 
1,3,4-oxadiazole derivatives lie in the field of liquid crystals 
and photosensitizer.
12 
Antimicrobial Activity 
Some,2-[5-(aryl)-[1,3,4]oxadiazole-2-ylsulfanyl]alkanoic 
acids  were  synthesized  and  studied  for  their  antibacterial 
activity.  These  compounds  were  prepared  from  aromatic 
carboxylic  acid  hydrazides.  Aromatic  carboxylic  acid 
hydrazides    on  refluxing  with  carbon  disulfide  and 
methanolic  potassium  hydroxide  and  then  on  subsequent 
acidification  with  hydrochloric  acid  furnish  5-aryl-1,3,4-
oxadiazole-2-thiones 2-Chloro alkanoic acids react with  in 
alkaline media and on acidification yield the title compounds  
These compounds were characterized by CHN analyses, IR, 
mass and 1H NMR spectral data. All the compounds were 
evaluated for their in vitro antibacterial activity against two 
Gram  negative  strains  (Escherichia  coli  and  Pseudomonas 
aeruginosa) and two Gram positive strains (Bacillus subtilis 
and  Staphylococcus  aureus)  and  their  minimum  inhibitory 
concentration (MIC) were determined. Antibacterial activity 
was  assessed  by  serial  two  fold  dilution  technique. 
Ciprofloxacin was used as a standard drug. Compounds  and  
exhibited significant activity against all the bacterial strains 
used in this study.
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A  series  of  new  1,3,4-oxadiazole  derivatives  having  6-
bromonaphthalene moiety are synthesized. 2-[(6-  bromo-2-
naphthyl)oxy]acetohydrazide  was  treated  with  various 
substituted aromatic acids in presence of POCl3 to give 2-
{[(6-bromo-2-naphthyl)oxy]methyl}-5-aryl-1,3,4-oxadiazole. 
Also the hydrazide on treating with CS2/KOH gave 5-{[(6-
bromo-2  naphthyl)oxy]methyl}-1,3,4-oxadiazole-2(3H)-
thione,  which  was  subjected  to  Mannich  reaction  to  get  a 
series of Mannich bases and with alkyl/aryl halide to give 2-
{[(6-bromo-2-naphthyl)oxy]methyl}-5-[(alkyl/aryl)thio]-
1,3,4-oxadiazole.  The  newly  synthesized  compounds  were 
characterized by analytical and spectral data. Antimicrobial 
activities of these compounds were carried out and some of 
them have exhibited good activity.
14   
N H N
O
S
B r
O
 
 
A  series  of  2-(3,4,5-trihydroxy  phenyl)-5-aryl-1,  3,4- 
oxadiazole (3) was synthesized from propyl gallate (1) and 
hydrazine  hydrate  in  presence  of  ethanol  to  give  3,  4,  5- 
trihydroxybenzohydrazide  (2)  followed  by  reaction  with 
phosphorus oxychloride and various aromatic acids. Structure 
of  the  synthesized  compounds  was  established  by 
physicochemical  property  analysis  and  spectral  data. Nupur Jaiswal et al. IRJP 2012, 3 (3) 
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Synthesized  compounds  were  subjected  to  antimicrobial, 
anti-fungal  and  anti-tubercular  activity.  Anti-microbial 
activity  was  carried  out  against  Escherichia  coli, 
Pseudomonas  aeruginosa,  Klebsiella  pneumoniae  and 
Staphylococcus  aureus  at  a  concentration  of  100  μg/ml. 
Streptomycin was used as standard. Anti-fungal activity was 
performed against Aspergillus niger, with test compounds at 
a concentration of 100μg/ml. Ketaconazole was the standard 
drug employed. Finally anti tubercular activity was observed 
at concentrations 100μg/ml on Mycobacterium tuberculosis 
using Rifampicin as standard.
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A series of 5-(2-aminophenyl)-1,3,4-oxadiazole-2(3H)-thione 
derivatives have been synthesized by mannich reaction. The 
reaction progress of the synthesized compounds was checked 
by TLC. The different in melting points of the synthesized 
compounds  indicated  the  formation  of  new  chemical 
analogues.  The  structures  of  the  newly  synthesized 
compounds  were  confirmed  by  IR  and  1H  NMR  spectral 
data. In vitro anti-microbial activity  was  evaluated by disc 
diffusion method for all the newly  synthesized compounds 
against gram +ve organisms such as Staphylococcus aureus, 
Streptococcus  pyogenes,  gram  –ve  organisms  such  as 
Escherichia  coli,  Klebsiella  aerogenes  and  fungus  such  as 
Candida  albicans.  Amikacin  and  ketoconazole  (10  μg/ml) 
were  used  as  reference  standard  for  antibacterial  and 
antifungal activity respectively. Compounds 1a, 1b, 1c and 1d 
showed moderate antibacterial and antifungal activities at a 
concentration of 100 μg/ml.
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A  series  of  Mannich  bases  5a-5h  were  synthesized  by  the 
reaction  of  5–{2–(ethylthio)–1H–  benzimidazol–1–yl}–
methyl–1,3,4–oxadiazole–2–thione 4 with formaldehyde and 
appropriate  amines  by  conventional  and  microwave 
techniques. The reaction rate and yields were enhanced under 
microwave  irradiation  technique  rather  than  conventional 
technique. Structures were characterized by means of spectral 
data  and  elemental  analyses.  The  antibacterial  screening 
against S. aureus, E. coli and P. aeruginosa at three different 
concentrations  revealed  that  compound  5f  is  significantly 
active.
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Some  new  3-acetyl-5-(3-chloro-1-benzo[b]thiophen-2-yl)-2-
substituted  phenyl-2,3-dihydro-1,3,4-oxadiazoles  and  2-(3-
chloro-1-benzo[b]thiophen-2-yl)-5-substituted  phenyl-1,3,4 
oxadiazoles  have  been  synthesized  and  evaluated  for 
antimicrobial  activity.  The  structures  of  newly  synthesized 
compounds  (4a-h)  and  (5a-h)  have  been  confirmed  by 
spectroscopic techniques such as IR, 1H NMR and elemental 
analysis.  All  the  compounds  were  screened  for  their 
antibacterial  activities  against  Staphylococcus  aureus, 
Bacillus  subtilis,  Escherichia  coli  and  Pseudomonas 
aeruginosa  and  for  antifungal  activity  against  Candida 
albicans  and  Asperigillus  niger.  The  compounds  exhibited 
significant  antibacterial  and  moderate  antifungal  activities. 
Compounds 4c and 4e were  found to be most potent with 
activities,  even  better  than  standard  drug  ciprofloxacin 
against S. aureus and B. subtilis.
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New  5-alkyl  and  3-(2,4-dimethylphenyl)  substituted  1,3,4-
oxadiazole-2-thione derivatives were synthesized by the ring 
closure  reactions  of  various  acylhydrazides  with  carbon 
disulphide.  Mannich  bases  for  some  of  these  compounds 
were  also  synthesized  by  condensation  with  benzaldehyde 
and primary amines. All new compounds were characterized 
by  spectral  data.  Most  of  them  were  tested  for  their 
antibacterial  and  antituberculostatic  activity.  The  in  vitro 
tuberculostatic  activity  of  1,3,4-oxadiazole-2-thione 
derivatives was studied against Mycobacterium tuberculosis 
using  Lowenstein  Jensen's  egg  medium  by  serial  twofold 
dilution and the retardation of the growth rate studied for six 
weeks at 37°C. The tuberculostatic concentration was 0.03 
g/ml. The antibacterial activity of the compounds was tested 
by agar plate diffusion against Staphylococcus aureus using 
tetracycline as the standard.
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A  series  of  novel  2,5-disubstituted  1,3,4-oxadiazole 
derivatives  were  synthesized  and  tested  for  their  in  vitro 
antimycobacterial  activity.  Some  compounds  showed 
interesting  activity  against  a  strain  of  Mycobacterium 
tuberculosis  H37Rv.  The  result  of  the  antimycobacterial 
activity  tests  revealed  that  2-(2-naphthyloxymethyl)-5-
phenoxymethyl-1,3,4-oxadiazole  (IVd)  exhibited  >  90%  
inhibition  at  MIC  ~6.25.  Our  results  indicate  that  the 
oxadiazole derivatives having a β-naphthyloxy methyl group 
at the C-2 position and a phenoxy methyl group at the C-5 
position  enhances  the  anti-tubercular  activity  of  the 
synthesized compounds.
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Synthesis of (ethyl 2- (1H Benzo [d] [1, 2, 3] triazole –1- yl] 
acetate)  and  (2H  –  benzo  [d]  [1,  2,  3]  triazole  –  1  –  yl 
acetohydrazine)  alongwith  their  derivatives  has  been  done. 
The  entire  synthesized  compounds  were  characterized  by 
UV,  IR  and  1H-NMR  specteoscopy.  The  Antimicrobial 
activity  of  the  synthesized  compounds  was  evaluated,  on 
Sreptococcus  aureus  and  Escherichia  coli.  The  present 
investigation  deals  with  the  synthesized  compounds 
possessing good antimicrobial activity. Ofloxacin was used 
as standard in a concentration of 30 µg/disc. Antimicrobial 
activity of the synthesized compounds and their derivatives 
D1-D5 were analyzed and maximum activity  was found in 
D2 against S. aureus.
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Copper(II) complexes of chromen-2-one-3-carboxyhydrazide 
and  2-(chromen-3'-onyl)-5-(aryl)-1,3,4-oxadiazole 
derivatives  have  been  synthesized.  The  structural  features 
have  been determined from their microanalytical, magnetic 
susceptibility, molar conductance, IR, UV VIS, 1H NMR and 
ESR spectral data. Distorted octahedral geometry for all the 
Cu(II)  complexes  is  proposed.  Molecular modeling  studies 
have  been  made  for  the rapid  structure  building,  geometry 
optimization and molecular display. These complexes show 
the  conductance  values,  supporting  their  non-electrolytic 
nature.  The  monomeric  nature  of  the  complexes  was 
confirmed  from  their  magnetic  susceptibility  values.  These 
complexes  have  been  screened  for  their  antimicrobial 
activities against some bacterial species like S.aureus, E.coli, 
Pseudomonas aeruginosa and few fungal strains C.albicans 
and Cryptococcus neoformans.
22 
N N
O
O O
O H
 
 
1,3,4-oxadiazole  and  its  derivatives  (3a-3e)  were  obtained 
from  the  intermediate  pyridine-4-carbohydrazide  (I)  from 
which schiffs base were obtained on treatment with various 
aromatic  aldehyde  ,further  on  condensation  with  acetic 
anhydride  produced  the  title  compounds.  The  remaining 
derivatives  (4f-4j,5,6)  were  also  obtained  from  the  same 
intermediate  pyridine-4-carbohydrazide  (I)  by  condensation 
with different cyclizing reagent like phosphoryl chloride. The 
structures  of  the  compounds  were  confirmed  by  IR,  1H 
NMR, MASS spectral data. All the synthesized compounds 
shown  to  significant  analgesic,  anti-inflammatory,  anti-
bacterial and anti-tubercular activities. But compound 4g and 
4j was found to possess better activity then others. Structure 
activity  relationship and mass  fragmentation has  also  been 
studied.
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The  synthesis  of  1-[(5-sustituted-1,3,4-oxadiazol-2-yl) 
methyl]-4-propylpiperazines  VIa-l  was  carried  out  by 
refluxing the 1-propylpiperazine II with ethylchloroacetate III 
in dry acetone in the presence of potassium carbonate and 
subsequent hydrazinolysis with hydrazine hydrate. Finally 2-
(4-propylpiperazin-1-yl)aceto- hydrazide V was treated with 
appropriate carboxylic acids in the presence of phosphorous 
oxy  chloride  to  produce  title  compounds.  The  newly 
synthesized  compounds  were  tested  for  its  antibacterial, 
antifungal  and  anthelmintic  activity.  Compound  VIg 
exhibited  potent  anthelmintic  activity  against  earthworms 
Eudrilus species, Megascoplex konkanensis and Pontoscotex 
corethruses at a dose of 2 mg/mL. The structures of newly 
synthesized  compounds  were  established  on  the  basis  of 
elemental analysis, IR, 1H NMR and mass spectral data.
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In  the  present  investigation,  four  1,3,4-bis-oxadiazole 
derivatives  were  synthesized  as  potential  antimicrobial 
agents.  The  compounds  are:  5,5’-dimercapto-bis-[1,3,4-
oxadiazol-2-yl]propane  (2a),  5,5’-dimercapto-bis-[1,3,4--
oxadiazol-2-yl]butane  (2b),  5,5’-dimercapto-bis-[1,3,4-
oxadiazol-2-yl]octane  (2c)  and  5,5’-dibenzylthio-bis-[1,3,4-
oxadiazol-2-yl]butane  (3).  The  above  newly  synthesized 
compounds  were  investigated  for  their  antibacterial, 
antifungal  and  mutagenic  activities.  The  results  of  the 
biological  activities  revealed  that  the  compounds  2a-c 
exhibited both antibacterial and antifungal activities against 
S. aureuss and B. subtilis. Compound 2a also showed activity 
against  P.  aeureoginosa.  All  the  above  compounds  and 
compound 3 exhibited activity against C. albicans. Genotoxic 
studies  showed  that  compound  2a  had  a  weak  base  pair 
substitution  mutagenicity  but  none  of  them  exhibited  a 
frameshift mutagenic action using Ames test.
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A  series  of  5-{3’-oxo-6’-(substituted  aryl)-2’,3’,4’,5’-
tetrahydropyridazin-2i-ylmethyl}-2-substituted  1,3,4-
oxadiazole  has  been  synthesized.  All  the  final  compounds 
were structurally elucidated on the basis of IR, 1H-NMR, MS 
data  and  elemental  analysis  and  screened  for  antibacterial, 
antifungal and antitubercular activity. All the compounds are 
evaluated  for  their  antibacterial  activity  against  E.coli,  S. 
aureus,  Micrococcus  luteus  and  Klebsiella  pneumoniae  by 
using cup plate technique in the nutrient agar at 100 μg/mL 
concentration. Antitubercular activity was determined using Nupur Jaiswal et al. IRJP 2012, 3 (3) 
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the  BACTEC  460  system.  All  the  synthesized  compounds 
were screened at 6.25 μg/mL against M. tuberculosis  H37 
Rv comparable with that of standard rifampicin and isoniazid. 
All  the  final  compounds  were  evaluated  for  antifungal 
activity against C. albicans and C. neoformans by using cup-
plate  method  in  the  Sabouraud  agar  media  The  zone  of 
inhibition  (mm)  of  each  compound  was  determined  and 
compared with standard drug fluconazole.
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In  this  study  a  series  of  new  1-(2-aryl-5-phenethyl-1,3,4-
oxadiazol-3(2H)-yl)ethanones  2a-e  was  synthesized  by  the 
cyclization  of  imines  1a-e  using  acetic  anhydride.  The 
products  were  evaluated  for  anti-bacterial  and  anti-fungal 
activity. Among the newly synthesized compounds, 1-(2-(4-
(dimethylamino)phenyl)-5-phenethyl-1,3,4-oxadiazol-3(2H)-
yl)ethanone  (2a)  and  1-(2-(4-chlorophenyl)-5-phenethyl-
1,3,4-oxadiazol-3(2H)-yl)ethanone  (2b)  were  found  to 
possess  maximum  activity  against  the  tested  strains  of  S. 
aureus  and  P.  aeruginosa.  It  was  concluded  that  para-
substitution  enhances  the  activity  of  synthesized 
oxadiazoles.
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New 5- phenyl- 1, 3, 4- oxadiazole- 2- thiol derivative was 
synthesized by the ring closure reactions of benzohydrazides 
with  carbon  disulphide  in  presence  of  ethanolic  KOH 
followed  by  substitution  with  secondary  amines  at  2nd 
position.  All  the  newly  synthesized  compounds  were 
characterized by IR, NMR and LC-MASS spectral data. Most 
of  them  were  tested  for  their  anti-inflammatory  and 
antibacterial  activity.  Antibacterial  activity  was  carried  out 
against P. vulgaris, P. aeuroginosa, E. coli by the cup plate 
method at a conc. of 50μg/ml and 100μg/ml. The standard 
drug used was Tetracycline and DMF was kept as control.
28 
N N
O
R
 
 
A  series  of  2-(Phenyl  substituted)-5-indole-1,3,4-oxadizole 
derivatives  were prepared. In this study, it was planned to 
incorporate  the  oxadiazole  ring  system  into  indole  ring. 
Synthesis of derivatives of 1,3,4-oxadiazoles from different 
benzaldehydes.  Characterization  of  the  synthesized 
compounds    along  with  their  antimicrobial  activity  on 
different  strains.  Standard  drugs  used  (Norfloxacin  and 
Fluconazole)  were  taken.  Out  of  these  4  compounds,  only 
three were found effective against bacterial strains and none 
of  the  synthesized  compound  was  found  effective  against 
fungal  strain.  The  compounds  which  were  active  against 
bacterial  strains  were  effective  at  a  much  higher 
concentration  as  compared  to  the  standard  drug  
norfloxacin.
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A survey of literature revealed that a slight modification in 
the structure can result in qualitative as well as quantitative 
changes in the activity, which prompted us to undertake the 
synthesis  of  various  new  2-Amino-5-(substituted)phenyl-
1,3,4-Oxadiazole  derivatives  with  the  aim  of  having 
improved  activity  and  lesser  toxicity.  The  synthesized 
compounds  were  evaluated  their  antimicrobial  properties 
against  Staphylococcus  aureus,  Escherichia  coli  and 
Pseudomonas  aeruginosa,  Candida  albicans,  and  using 
microbroth  dilution  method.  Standard  antibiotics  namely 
Norfloxacin  was  used  for  comparison  with  antibacterial 
activity.
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3,5-bis(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)azo  dyes  were 
synthesized  by  multistep  reaction  sequences,  which  is 
diazotized and coupled with different napthols and quinoline. 
Structure  of  newly  synthesized  compounds  were 
characterized and confirmed by IR, NMR and Mass spectral 
studies. The newly synthesized azo dye fused with (5-(furan-
2-yl)-1,3,4-oxadiazole) were screened for their acute toxicity 
and  gross  behavioral  studies  and  in-vitro  anti-microbial 
activity.  Synthesized  compounds  exhibit  significant 
biological activity and can certainly hold greater promise in 
discovering  safer  biologically  active  molecules.  The 
antimicrobial  activity  of  the  test  compounds  (5a-g)  were 
screened  by  agar  well  radial  diffusion  method  against 
bacterial  strains  belonging  to  Staphylococcus  aureus, 
Pseudomonas  aeruginosa,  Bacillus  subtilis  and  Escherchia 
coli  and  fungal  strains  Candida  albicans  and  Candida 
parapsilosis respectively.
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A  series  of  2-[5-(substituted  sulfanyl)-1,3,4-oxadiazol-2-
yl]phenol derivatives were prepared. 1, 3, 4 oxadiazole was 
synthesized  by  condensation  reaction  between  2- 
hydroxybenzohydrazine and carbon disulfide. This derivative 
on  treatment  with  different  aromatic  halides  produced  the Nupur Jaiswal et al. IRJP 2012, 3 (3) 
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desired final products. The in-vitro antibacterial activity  of 
synthesized compound was tested against Gram-positive and 
Gram-negative  microorganisms  (Staphylococcus  aureus 
ATCC  9144,  Bacillus  subtilis  ATCC  6633,  Pseudomonas 
aeruginosa MTCC No. 1688, Gram negative: Escherichia coli 
ATCC  25922)  by  filter  paper  disc  method.  The  in-vitro 
antifungal  activity  was  tested  against  Candida  albicans  by 
filter  paper  disc  method.  All  the  compounds  showed  good 
activity against all cultures.
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A  series  of  N-(substituted  aryl  -1,3,4-oxadiazole  -2  yl) 
methyl-N-(4H-1,2,4 –triazol-4 yl) benzamide derivative was 
synthesized by condensation of 4 amino triazole and benzoyl 
chloride.  The  identification  and  characterization  of  the 
synthesized  compounds  were  carried  out  by  Elemental 
analysis, melting point,Thin Layer Chromatography, FT-IR, 
NMR data to ascertain that all synthesized compounds were 
of  different  chemical  nature  than  the  respective  parent 
compound.  Antimicrobial  and  antifungal  activities  of  the 
final compounds have been evaluated and all the compounds 
have  shown  significant  inhibition  of  bacterial  and  fungal 
growth.
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Alkyl,  alkenyl,  sulfonyl,  thiocarbamates  and  Mannich 
derivatives  were  synthesized and  characterized  through  IR, 
NMR, and Elemental analysis. It is of interest to report the 
isomerization rearrangement of propynyl to allene group in 
Mannich reaction under basic condition. The most promising 
compound  as  antibacterial  agent  was  5-(pyridyl)-1,  3,  4- 
oxadiazole-2-benzylthiocarbamates.  The  MIC  for  the 
synthesized  compounds  indicates  that  the  conversion  of 
sulfhydryl  group  in  1,3,4-oxidazole  into  alkyl  3,  allene  8, 
sulfonyl  13  derivatives  and mannich  product  19  showed  a 
weak antimicrobial activity. However, thiocarbamates 16 and 
17 were effective against Gram positive and Gram negative 
bacteria  with  less  activity  against  fungi.  These  results 
promote our interest to investigate further the thiocarbamate 
series.
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Microwave-assisted as well as conventional synthesis of 5-
substituted-2-(2-methyl-4-nitro-1-  imidazomethyl)-1,3,4-
oxadiazoles containing the nitroimidazole moiety is carried 
out and their antibacterial, antifungal and anti-inflammatory 
activity  is  reported.  Studies  on  the  antibacterial activity  of 
synthesized compounds 7 have been carried out against four 
pathogenic  organisms,  viz.,  Staphylococcus  aureus  (G+), 
Klebsiella  pneumoniae  (G–),  Escherichia  coli  (G–)  and 
Pseudomonas aeruginosa (G–). The antibacterial activity of 
the newly synthesized compounds in the present investigation 
was assessed by the cup-plate method.
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6–Methyl–4–aryl–5-(5-phenyl-1,3, 4 – oxadiazol -2- yl) -1, 2, 
3, 4 tetrahydropyrimidine-2(1H)-one have been synthesized 
and compound 3e has significant effect against Streptococcus 
pneumonia(+ve)  and  3b  has  significant  activity  effect 
Escherichia coli. The antibacterial activity are performed by 
cup and plate method (Disc diffusion technique) 40-45 fresh 
cultures of  bacteria are obtained by inoculating bacteria in 
Muller-Hinton broth and incubated at 370 ±2OC for 18-24 
hours in B O D incubator. This culture is mixed with nutrient 
agar  20%  (High  Media)  and  poured  into  petri  dishes 
aseptically. After solidification of the media five  bores are 
made  at  equal  distance  by  using  sterile  cork  borer  (8mm 
diameter),  different  concentrations  of  standard  drug  and 
synthesized  compounds  are  introduced  into  these  cups. 
Dimethyl formamide (DMF) is used as a control.
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In  the  present  study,  a  new  1,3,4-  oxadiazole  and  1,3,4-
thiadiazole  derivatives  were  synthesized.  Benzol  hydrazine 
(2) was prepared by the hydrazinolysis  of methyl benzoate 
(1) with hydrazine hydrate in abs. ethanol. Condensation of 
(2) with chloroacetic acid in phosphoruse oxychloride results 
in  the  formation  of  2-phenyl-5-chloromethyl-1,3,4-
oxadiazole (3), which on reaction with 2,5-dimercapto-1,3,4-
thiadiazole  in  pyridine  affords  2,5-di-[5-  phenyl-1,3,4-
oxadiazole-2-thiomethyl]-1,3,4-thiadiazole  (5).  The  newly 
synthesized  compounds  were  characterized  by  CHNS 
elemental  analysis,  IR  and  NMR  spectral  data.  The newly 
synthesized  compounds  were  screened  for  their  in  vitro 
antibacterial  activity.  The  prepared  compounds  manifested 
promising biological activity.
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A new series of 2, 5-disubstituted-1, 3, 4-oxadiazoles were 
prepared by reaction of nicotinic acid hydrazide with various 
substituted aromatic acids in presence of POCl3, as potential 
biological active agents. The newly synthesized compounds 
were confirmed from IR, MASS and 1H NMR spectral data. 
Some  of  the  synthesized  compounds  showed  very  good 
antifungal  activity  when  compared  to  antibacterial activity. 
Ten  compounds  from  the  series  were  screened  for  their 
antibacterial  and  antifungal  activity.  Antibacterial  activity 
was  carried  out  against  S.aureus,  P.aeruginosa,  E.coli  and 
B.subtilis by the cup plate method at a conc. of 100 μg/ml. 
The standard drug used was Ampicillin and DMF was kept as 
solvent  control.  The  antifungal  studies  were  carried  out 
against fungus C.albicans and A.niger using Griseofulvin as 
standard.
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A series of 2, 2’-(5-nitrobenzene-1, 3-diyl) bis (5-alkyl-1, 3, 
4-oxadiazole)  (2a-e)  5,5'-(5-nitrobenzene-1,3-diyl)bis(1,3,4-
oxadiazole-2-thiol)  (3)  and  5,5'-(5-nitrobenzene-1,3-
diyl)bis(4-amino-4H-1,2,4-triazole-3-thiol(5)  were  obtained 
via reaction of 5-nitro iso-phthalic dihydrazide (1). All these 
newly  synthesized  compounds  were  characterized  by  IR, 
NMR  and  Mass,  spectral  studies.  Newly  synthesized 
compound displayed potent antibacterial and antinociceptive 
activity. Antibacterial activities were determined by the well-
diffusion method.
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The  synthesis  of  1-[(5-sustituted-1,3,4-oxadiazol-2-yl) 
methyl]-4-benzylpiperazines  VIa-j  was  carried  out  by 
refluxing  the  1-benzylpiperazine  II  with  ethylchloroacetate 
III in dry acetone in the presence of potassium carbonate and 
subsequent hydrazinolysis with hydrazine hydrate. Finally 2-
(4-benzylpiperazin-1-yl)aceto- hydrazide V was treated with 
appropriate carboxylic acids in the presence of phosphorous 
oxy  chloride  to  produce  title  compounds.  All  the  title 
compounds  (VIa-j)  were  screened  for  anticancer  activity 
using HBL-100 cell lines by MTT method and antibacterial 
activity against B. subtiliis, S. aureus, E.coli and P. vulgaris. 
The  structures  of  newly  synthesized  compounds  were 
established on the basis of elemental analysis, IR, 1H NMR 
and mass spectral data.
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Reaction  of  isonicotinohydrazide  with  different  aromatic 
aldehydes  under  the  microwave  irradiation  gives  Schiff’s 
bases.  These  Schiff’s  bases  were  converted  into  1,  3,  4-
oxadiazole  derivatives  by  treating  with  acetic  anhydride 
under  the  microwave  irradiation.  The  structures  of  the 
compounds  were  confirmed  by  elemental  analysis,  IR, 
1HNMR  and  Mass  spectral  data’s  .The  synthesized 
compounds  were  screened  for  antimicrobial,  analgesic  and 
anti-inflammatory activities. The antibacterial activity of all 
the  synthesized  compounds  (2a‐m)  were  examined  against 
Gram‐positive  (S.aureus)  and  Gram‐negative  (E.coli  ) 
organisms by measuring zone of inhibition. The antibacterial 
activity was performed by Agar diffusion method [27,28] at 
the concentration level 200 ,100 .50 μg/mL ciprofloxcin was 
used as standard drug at concentration of 50 μg /ml. 
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CONCLUSION 
This literature review reveals that 1, 3, 4 Oxadiazole have 
diverse biological activity, and very simple synthetic process 
too. It has shown the good  anti-microbial activities. By the 
present scenario it can be concluded that 1, 3, 4 Oxadiazole 
have remarkable anti –microbial activity. 
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